Latest filing published 23 Jun 2017 for Regeneron Pharmaceuticals, INC., €123k.
Filing timeline
BuySaleInsider track record
Michael S. Aberman: trading record in brief
Michael S. Aberman is a declared insider of Regeneron Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 22 March 2010 to 22 June 2017, the count stands at 116 filings.
Every open-market trade on record is a sale: 72 sales worth €13.9M. Outside the open market, there are 24 share grants and 20 option exercises. So far in 2017, the count stands at no purchases and 12 sales.
The record was last updated on 23 June 2017 with a share grant (€123k) in Regeneron Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael S. Aberman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 270 shares@ US$510.025.5% of flowCommon StockSEC:0001708138-17-000011:1
- 1,961 shares@ US$510.0240.2% of flowCommon StockSEC:0001708138-17-000011:2
- 395 shares@ US$525.218.4% of flowCommon StockSEC:0001708138-17-000011:3
- 100 shares@ US$526.022.1% of flowCommon StockSEC:0001708138-17-000011:4
- 100 shares@ US$529.612.1% of flowCommon StockSEC:0001708138-17-000011:5
- 100 shares@ US$530.662.1% of flowCommon StockSEC:0001708138-17-000011:6
- 274 shares@ US$531.515.9% of flowCommon StockSEC:0001708138-17-000011:7
- 200 shares@ US$532.274.3% of flowCommon StockSEC:0001708138-17-000011:8
- 200 shares@ US$533.484.3% of flowCommon StockSEC:0001708138-17-000011:9
- 200 shares@ US$534.514.3% of flowCommon StockSEC:0001708138-17-000011:10
- 400 shares@ US$536.528.6% of flowCommon StockSEC:0001708138-17-000011:11
- 100 shares@ US$537.502.2% of flowCommon StockSEC:0001708138-17-000011:12
- 100 shares@ US$538.302.2% of flowCommon StockSEC:0001708138-17-000011:13
- 100 shares@ US$541.002.2% of flowCommon StockSEC:0001708138-17-000011:14
- 4,500 shares@ US$30.635.5% of flowCommon StockSEC:0001708138-17-000011:0
- 4,000 shares@ US$24.00Common StockSEC:0001237899-15-000067:0
- 5,157 shares@ US$476.50Common StockSEC:0001237899-15-000027:0
- 300 shares@ US$474.79Common StockSEC:0001237899-15-000027:1
- 200 shares@ US$475.83Common StockSEC:0001237899-15-000027:2
- 740 shares@ US$476.53Common StockSEC:0001237899-15-000027:3
- 573 shares@ US$477.59Common StockSEC:0001237899-15-000027:4
- 530 shares@ US$478.46Common StockSEC:0001237899-15-000027:5
- 500 shares@ US$479.39Common StockSEC:0001237899-15-000027:6
- 800 shares@ US$480.70Common StockSEC:0001237899-15-000027:7
- 1,100 shares@ US$481.59Common StockSEC:0001237899-15-000027:8
25 of 116 declarations
